17 subjects with a diagnosis of schizophrenia and hallucinations in their case history were compared with 16 subjects of a reference group regarding the appearance of a perception of streaming in a presentation of pitch alternating tones. One scale going up and down was used as part of a stimulus and the same scale going down and up as the other part (as distractor). The amplitude of the distractor was varied in order to make the perceptual regrouping (streaming) evident, which normally occurs when the amplitude approaches the same level in the two stimuli. Sixteen presentations were made. The subjects of the reference group began to hear the streaming after the sixth presentation and all of them heard it at the eighth. At the eleventh presentation some ceased to perceive any streaming and none heard it after the fourteenth presentation. In the schizophrenic group none showed a normal pattern. Overall, less than half of the schizophrenic probands heard a streaming when subjects in the reference group did. Amongst those who did, a few heard it early and kept hearing it to the end. Others started to hear it late and kept hearing it to the end, while a few heard it on and off. The remarkable aberrant grouping strategies among the schizophrenics are discussed in relation to current ideas on perceptual disturbances of the illness.

This content is only available via PDF.
© 1997 S. Karger AG, Basel
1997
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.